AC
DCOY

Armistice Capital’s Decoy Therapeutics DCOY Stock Holding History

Armistice Capital’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-126
Closed -$54.1K – 317
2024
Q2 		$54.1K Buy
126
+68
+117% +$44.9K ﹤0.01% 237
2024
Q1 		$44.4K Sell
58
-3
-5% -$2.58K ﹤0.01% 315
2023
Q4 		$57.2K Sell
61
-95
-61% -$94.8K ﹤0.01% 262
2023
Q3 		$148K Buy
156
+80
+105% +$106K ﹤0.01% 211
2023
Q2 		$163K Buy
+76
New +$174K ﹤0.01% 183

Other funds holding DCOY

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return